EXEL |
Exelixis, Inc. |
0 |
4.37% |
|
|
|
|
|
N/A |
0.00% |
35.76% |
25.36% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
4.23% |
|
|
|
|
|
N/A |
0.00% |
52.38% |
63.01% |
---|
NTRA |
Natera, Inc. |
0 |
4.19% |
|
|
|
|
|
N/A |
0.00% |
53.42% |
16.92% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
0 |
4.07% |
|
|
|
|
|
N/A |
0.00% |
34.71% |
19.89% |
---|
ARGX |
argenx SE |
0 |
3.94% |
|
|
|
|
|
N/A |
0.00% |
31.77% |
27.68% |
---|
CORT |
Corcept Therapeutics Incorporated |
0 |
3.82% |
|
|
|
|
|
N/A |
0.00% |
65.42% |
36.69% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
|
3.79% |
|
|
|
|
|
|
|
|
|
---|
GILD |
Gilead Sciences, Inc. |
0 |
3.74% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
---|
INCY |
Incyte Corporation |
0 |
3.59% |
|
|
|
|
|
N/A |
0.00% |
42.37% |
45.07% |
---|
RGEN |
Repligen Corporation |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
50.01% |
19.22% |
---|
WAT |
Waters Corporation |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
34.93% |
24.08% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
3.55% |
|
|
|
|
|
N/A |
0.00% |
42.34% |
25.01% |
---|
ALKS |
Alkermes plc |
0 |
3.42% |
|
|
|
|
|
N/A |
0.00% |
55.46% |
60.80% |
---|
UTHR |
United Therapeutics Corporation |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
32.21% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
0 |
3.36% |
|
|
|
|
|
N/A |
0.00% |
82.04% |
56.49% |
---|
BNTX |
BioNTech SE |
0 |
3.25% |
|
|
|
|
|
N/A |
0.00% |
45.15% |
32.29% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
0 |
3.21% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
35.06% |
---|
ILMN |
Illumina, Inc. |
0 |
3.16% |
|
|
|
|
|
N/A |
0.00% |
41.31% |
22.70% |
---|
BRKR |
Bruker Corporation |
0 |
3.13% |
|
|
|
|
|
N/A |
0.00% |
46.26% |
47.89% |
---|
HALO |
Halozyme Therapeutics, Inc. |
0 |
3.10% |
|
|
|
|
|
N/A |
0.00% |
37.56% |
28.21% |
---|
GMAB |
Genmab A/S |
0 |
3.05% |
|
|
|
|
|
N/A |
0.00% |
74.56% |
47.75% |
---|
MTD |
Mettler-Toledo International Inc. |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
33.35% |
20.45% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
29.42% |
23.44% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
2.85% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
10.53% |
---|
BIIB |
Biogen Inc. |
0 |
2.79% |
|
|
|
|
|
N/A |
0.00% |
37.26% |
39.84% |
---|
AMGN |
Amgen Inc. |
0 |
2.73% |
|
|
|
|
|
N/A |
0.00% |
34.50% |
47.20% |
---|
EXAS |
Exact Sciences Corporation |
0 |
2.72% |
|
|
|
|
|
N/A |
0.00% |
46.55% |
11.01% |
---|
BGNE |
BeiGene, Ltd. (ADR) |
|
2.69% |
|
|
|
|
|
|
|
|
|
---|
MRNA |
Moderna, Inc. |
0 |
2.45% |
|
|
|
|
|
N/A |
0.00% |
67.24% |
33.78% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.41% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
---|
|
US Dollar |
|
0.08% |
|
|
|
|
|
|
|
|
|
---|